BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7812000)

  • 21. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins.
    Hsu HL; Cheng JT; Chen Q; Baer R
    Mol Cell Biol; 1991 Jun; 11(6):3037-42. PubMed ID: 2038315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the inhibition of MyoD activity by ITF-2B and full-length E12/E47.
    Petropoulos H; Skerjanc IS
    J Biol Chem; 2000 Aug; 275(33):25095-101. PubMed ID: 10833525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The HAND1 basic helix-loop-helix transcription factor regulates trophoblast differentiation via multiple mechanisms.
    Scott IC; Anson-Cartwright L; Riley P; Reda D; Cross JC
    Mol Cell Biol; 2000 Jan; 20(2):530-41. PubMed ID: 10611232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis.
    Kallianpur AR; Jordan JE; Brandt SJ
    Blood; 1994 Mar; 83(5):1200-8. PubMed ID: 8118024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
    Huang S; Qiu Y; Stein RW; Brandt SJ
    Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF-kappaB activation in premalignant mouse tal-1/scl thymocytes and tumors.
    O'Neil J; Ventura JJ; Cusson N; Kelliher M
    Blood; 2003 Oct; 102(7):2593-6. PubMed ID: 12816868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
    Hsu HL; Wadman I; Tsan JT; Baer R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancer-specific modulation of E protein activity.
    Markus M; Du Z; Benezra R
    J Biol Chem; 2002 Feb; 277(8):6469-77. PubMed ID: 11724804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
    Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
    Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lineage-restricted regulation of the murine SCL/TAL-1 promoter.
    Bockamp EO; McLaughlin F; Murrell AM; Göttgens B; Robb L; Begley CG; Green AR
    Blood; 1995 Aug; 86(4):1502-14. PubMed ID: 7632958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear localization of the SCL/TAL1 basic helix-loop-helix protein is not dependent on the presence of the basic domain.
    Bernard M; Smit L; Macintyre E; Matthieu-Mahul D; Pulford K
    Blood; 1995 Jun; 85(11):3356-7. PubMed ID: 7756670
    [No Abstract]   [Full Text] [Related]  

  • 32. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1.
    Lécuyer E; Herblot S; Saint-Denis M; Martin R; Begley CG; Porcher C; Orkin SH; Hoang T
    Blood; 2002 Oct; 100(7):2430-40. PubMed ID: 12239153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcription factors of the bHLH and LIM families: synergistic mediators of T cell acute leukemia?
    Baer R; Hwang LY; Bash RO
    Curr Top Microbiol Immunol; 1997; 220():55-65. PubMed ID: 9103675
    [No Abstract]   [Full Text] [Related]  

  • 34. A splice variant of the ITF-2 transcript encodes a transcription factor that inhibits MyoD activity.
    Skerjanc IS; Truong J; Filion P; McBurney MW
    J Biol Chem; 1996 Feb; 271(7):3555-61. PubMed ID: 8631961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The stem cell leukaemia (SCL) gene: a critical regulator of haemopoietic and vascular development.
    Barton LM; Göttgens B; Green AR
    Int J Biochem Cell Biol; 1999 Oct; 31(10):1193-207. PubMed ID: 10582347
    [No Abstract]   [Full Text] [Related]  

  • 37. Repression of muscle-specific gene activation by the murine Twist protein.
    Hebrok M; Füchtbauer A; Füchtbauer EM
    Exp Cell Res; 1997 May; 232(2):295-303. PubMed ID: 9168805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The SCL gene product: a positive regulator of erythroid differentiation.
    Aplan PD; Nakahara K; Orkin SH; Kirsch IR
    EMBO J; 1992 Nov; 11(11):4073-81. PubMed ID: 1396592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding.
    Porcher C; Liao EC; Fujiwara Y; Zon LI; Orkin SH
    Development; 1999 Oct; 126(20):4603-15. PubMed ID: 10498694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: the effect of enforced expression of the SCL transcription factor.
    Tanigawa T; Nicola N; McArthur GA; Strasser A; Begley CG
    Blood; 1995 Jan; 85(2):379-90. PubMed ID: 7811994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.